These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8634515)
1. Guillain-Barré as an autoimmune disease. Shoenfeld Y; George J; Peter JB Int Arch Allergy Immunol; 1996 Apr; 109(4):318-26. PubMed ID: 8634515 [TBL] [Abstract][Full Text] [Related]
2. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome. Zhu J; Mix E; Link H J Neuroimmunol; 1998 Apr; 84(1):40-52. PubMed ID: 9600707 [TBL] [Abstract][Full Text] [Related]
3. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis]. Hartung HP; Heininger K; Toyka KV Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228 [TBL] [Abstract][Full Text] [Related]
4. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome. Hartung HP; Toyka KV Ann Neurol; 1990; 27 Suppl():S57-63. PubMed ID: 2194429 [TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. van der Meché FG; van Doorn PA Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214 [TBL] [Abstract][Full Text] [Related]
7. [Guillain-Barré syndrome. Current status]. Masson C Presse Med; 1983 Mar; 12(11):689-93. PubMed ID: 6188143 [TBL] [Abstract][Full Text] [Related]
8. Cellular immunity in inflammatory autoimmune neuropathies. Mäurer M; Toyka KV; Gold R Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S7-15. PubMed ID: 12690655 [TBL] [Abstract][Full Text] [Related]
9. P2-reactive T cells in inflammatory demyelination of the peripheral nerve. Rostami AM J Infect Dis; 1997 Dec; 176 Suppl 2():S160-3. PubMed ID: 9396703 [TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I. Hartung HP; Pollard JD; Harvey GK; Toyka KV Muscle Nerve; 1995 Feb; 18(2):137-53. PubMed ID: 7823972 [TBL] [Abstract][Full Text] [Related]
11. Future developments in the treatment of immune-mediated polyneuropathies. van der Meché FG; van Doorn PA Eur Neurol; 1997; 38(3):230-7. PubMed ID: 9363836 [TBL] [Abstract][Full Text] [Related]
14. Experimental neuritis induced by a mixture of neural antigens and influenza vaccines. A possible model for Guillain-Barré syndrome. Hjorth RN; Bonde GM; Piner E; Hartzell RW; Rorke LB; Rubin BA J Neuroimmunol; 1984 Feb; 6(1):1-8. PubMed ID: 6707195 [TBL] [Abstract][Full Text] [Related]
15. Late onset of Guillain-Barré syndrome. Poser CM; Behan PO J Neuroimmunol; 1982 Aug; 3(1):27-41. PubMed ID: 6124552 [TBL] [Abstract][Full Text] [Related]